Eat your salmon: study shows fatty fish aids in cancer prevention
the ONA take:
Although recent studies have challenged the idea that eating more fatty fish is good for you, a new study published in the journal Nutrition and Cancer supports the theory that eating more fish can help to prevent cancer.
Investigators from an international team built on evidence that a regular low-dose of aspirin can decrease the risk for adenocarcinoma by decreasing the activity of cyclooxygenase-2 (COX-2), an enzyme that contributes to the progression of adenocarcinoma, by proposing that omega-3 fatty acids, which are found in fatty fish, can also inhibit COX-2. A high proportion of the cancers that originate in the breast, prostate, pancreas, colon, and GI tract are adenocarcinomas.
However, the authors of the study caution that it’s not just the amount of fish one consumes that can have an effect on the development of cancer, but also the kind of fish and how it is cooked. For example, in Italian subjects who consumed fish more than twice a week and cooked the fish in olive oil (rather than frying or preserving in salt) were found to be at a significantly lower risk for a variety of cancers.
It was also noted in this study that COX-2 is highly expressed in pre-malignant and early-stage adenocarcinomas, which is why the omega-3 fats are more effective in preventing cancer rather than as a therapeutic agent.
New study supports the theory that eating more fish can help to prevent cancer.
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- Aggressive Therapy Provides No Additional Advantage in Metastatic Prostate Cancer
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- FDA, ASHP Actions to Prevent or Manage Chemotherapy Drug Shortages
- Breast Cancer Screening Recommendations Not Completely Reflective of Race, Age
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Approach and Management of Checkpoint Inhibitor-related Immune Hepatitis
- Revised AJCC8 Demonstrates Superior Tumor Classification for HNCSCC
- Oral Androgen Receptor Inhibitor Granted FDA Approval for Nonmetastatic CRPC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|